Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients.

Objective: The aim of this study was to test the hypothesis that omega-3 fatty acids have an effect on serum lipids and inflammation markers in chronic hemodialysis (HD) patients.

Design: The study followed a single-blind, randomized, crossover design.

Setting: The study was conducted at the Hemodialysis Unit of the Laikon General Hospital in Athens, Greece.